Invesco
TYRA icon

Invesco’s Tyra Biosciences TYRA Stock Holding History

Invesco’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.18M Sell
109,052
-20,383
-16% -$660K ﹤0.01% 2266
2025
Q4 		$3.4M Buy
129,435
+113,925
+735% +$2.09M ﹤0.01% 2410
2025
Q3 		$217K Buy
+15,510
New +$177K ﹤0.01% 3542

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Invesco's TYRA Position: Q1 2026 in Review

Invesco reduced its Tyra Biosciences (TYRA) stake by 16% in Q1 2026, selling an estimated $660K and leaving 109,052 shares worth $4.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2266.

Invesco first reported a position in TYRA in Q3 2025 and has held it in 3 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Invesco held 109,052 shares of Tyra Biosciences worth $4.18M as of Q1 2026.
  • Invesco sold 20,383 Tyra Biosciences shares in Q1 2026, an estimated $660K.
  • Tyra Biosciences made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2266 holding.
  • Invesco first reported a position in Tyra Biosciences in Q3 2025 and has held it in 3 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.